Faecal pharmacokinetics of orally administered vancomycin in patients with suspected <it>Clostridium difficile </it>infection

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected <it>Clostridium difficile </it>infection

<p>Abstract</p> <p>Background</p> <p>Oral vancomycin (125 mg qid) is recommended as treatment of severe <it>Clostridium difficile </it>infection (CDI). Higher doses (250 or 500 mg qid) are sometimes recommended for patients with very severe CDI, without supp...

Full description

Bibliographic Details
Main Authors: Fortier Louis-Charles, Sirard Stephanie, Carrier Julie C, Frost Eric H, Pepin Jacques, Gonzales Milagros, Valiquette Louis
Format: Article
Language:English
Published: BMC 2010-12-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/10/363

Internet

http://www.biomedcentral.com/1471-2334/10/363

Similar Items